MedTrace Logo

Vitamin D3, Folic Acid and Fexofenadine in Healthy Volunteers

NCT01856348 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2013-08-13

No results posted yet for this study

Summary

The study is conducted to assess the effect of a vitamin D3 supplementation on the activities of two intestinal transporters and on the pharmacokinetics of the transporter substrates folic acid and fexofenadine.

* Trial with medicinal product

Conditions

  • Physiological Effects of Vitamin D

Interventions

DRUG

Vitamin D

Sponsors & Collaborators

  • University of Zurich

    lead OTHER

Principal Investigators

  • Gerd A Kullak-Ublick, Prof MD · University Hospital Zurich, Pharmacology and Toxicology

Study Design

Allocation
NA
Purpose
PREVENTION
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-05-31
Primary Completion
2013-07-31
Completion
2013-07-31

Countries

  • Switzerland

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01856348 on ClinicalTrials.gov